However, in all instances, MYC-dependent cancers were used as model systems and resistance was universally conferred through reactivation of MYC expression, despite being mediated by different mechanisms, such as activation of Wnt signaling15,29, co-regulation by GLI220, or phosphorylation of BRD419. The gene discussed is MYC; the disease is cancer.